Paul Grayson's most recent trade in Skye Bioscience Inc was a trade of 135,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Skye Bioscience Inc
|
Paul Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
Skye Bioscience Inc
|
Paul Grayson | Director | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 86,244 | 259,701 (0%) | 0% | 5.0 | 430,358 | Common Stock |
Skye Bioscience Inc
|
Paul Grayson | Director | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 307 | 345,945 (0%) | 0% | 5.6 | 1,704 | Common Stock |
Skye Bioscience Inc
|
Paul Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) |